PROQR THERAPEUTICS NV (PRQR) Stock Earnings & Estimates
USA - NASDAQ:PRQR - NL0010872495 - Common Stock
2.8 USD
+0.09 (+3.32%)
3.2 USD
+0.4 (+14.29%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.8M 100.00% | 9.525M 98.44% | 19.545M 105.20% | 16.979M -13.13% | 12.954M -23.71% | 10.732M -17.15% | 75.032M 599.14% | 96.535M 28.66% | 187.53M 94.26% | 250.78M 33.73% | 390.55M 55.73% | |
| EBITDA YoY % growth | -62.2M -13.38% | -29.346M 52.82% | -27.711M 5.57% | -53.384M -92.64% | -59.368M -11.21% | -16.014M 73.03% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -64.72M -13.17% | -31.859M 50.77% | -30.472M 4.35% | -43.022M -41.19% | -52.198M -21.33% | -69.541M -33.23% | -36.668M 47.27% | 19.134M 152.18% | 350.31M 1,730.82% | 628.41M 79.39% | 1.093B 73.93% | |
| Operating Margin | -1,348.33% | -334.48% | -155.91% | -253.39% | -402.95% | -647.98% | -48.87% | 19.82% | 186.80% | 250.58% | 279.86% | |
| EPS YoY % growth | -0.91 6.19% | -0.35 61.54% | -0.31 10.40% | -0.42 -34.15% | -0.53 -24.95% | -0.51 3.53% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 -5.01% | -0.11 -22.64% | -0.13 -28.04% | -0.13 -10.16% | -0.14 -32.40% | -0.15 -29.33% |
| Revenue Q2Q % growth | 4.456M 15.95% | 3.852M -10.56% | 3.669M -18.81% | 3.303M -13.47% | 2.956M -33.66% | 2.726M -29.23% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.951M -25.65% | -8.974M 10.98% | -11.938M -10.37% | -13.509M -10.29% | -14.867M -35.75% | -16.103M -79.44% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.12 -300.00% | -0.08 | -0.04 | -43.58% |
| Q1 2025 Q2Q % growth | -0.10 -11.11% | -0.09 | -0.01 | -6.02% |
| Q4 2024 Q2Q % growth | -0.09 -33.70% | -0.09 | 0.00 | 0.34% |
| Q3 2024 Q2Q % growth | -0.10 -42.86% | -0.11 | 0.01 | 7.09% |
| Q2 2024 Q2Q % growth | -0.03 70.00% | -0.13 | 0.10 | 76.42% |
| Q1 2024 Q2Q % growth | -0.09 18.18% | -0.11 | 0.02 | 19.45% |
| Q4 2023 Q2Q % growth | -0.07 56.25% | 0.01 | -0.08 | -732.51% |
| Q3 2023 Q2Q % growth | -0.07 79.41% | -0.09 | 0.02 | 19.37% |
| Q2 2023 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 11.76% |
| Q1 2023 Q2Q % growth | -0.11 45.00% | -0.12 | 0.01 | 8.34% |
| Q4 2022 Q2Q % growth | -0.16 38.46% | -0.18 | 0.02 | 12.13% |
| Q3 2022 Q2Q % growth | -0.34 -54.55% | -0.21 | -0.13 | -58.31% |
| Q2 2022 Q2Q % growth | -0.21 12.50% | -0.22 | 0.01 | 4.64% |
| Q1 2022 Q2Q % growth | -0.20 20.00% | -0.24 | 0.04 | 16.75% |
| Q4 2021 Q2Q % growth | -0.26 | -0.19 | -0.07 | -37.23% |
| Q3 2021 Q2Q % growth | -0.22 15.38% | -0.21 | -0.01 | -5.20% |
| Q2 2021 Q2Q % growth | -0.24 -200.00% | -0.24 | 0.00 | 0.80% |
| Q1 2021 Q2Q % growth | -0.25 21.88% | -0.25 | 0.00 | 1.84% |
| Q4 2020 Q2Q % growth | -0.26 33.33% | -0.26 | 0.00 | -1.57% |
| Q3 2020 Q2Q % growth | -0.26 16.13% | -0.31 | 0.05 | 15.21% |
| Q2 2020 Q2Q % growth | -0.08 75.00% | -0.33 | 0.25 | 76.06% |
| Q1 2020 Q2Q % growth | -0.32 11.15% | -0.35 | 0.03 | 8.27% |
| Q4 2019 Q2Q % growth | -0.39 | -0.36 | -0.03 | -8.47% |
| Q3 2019 Q2Q % growth | -0.31 | -0.35 | 0.04 | 11.62% |
| Q2 2019 Q2Q % growth | -0.32 | -0.39 | 0.07 | 18.12% |
| Q1 2019 Q2Q % growth | -0.36 | -0.37 | 0.01 | 3.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 3.817M -39.46% | 4.541M | -724K | -15.94% |
| Q1 2025 Q2Q % growth | 4.519M 1.55% | 4.616M | -97K | -2.10% |
| Q4 2024 Q2Q % growth | 4.307M -30.70% | 6.011M | -1.704M | -28.35% |
| Q3 2024 Q2Q % growth | 3.843M 180.51% | 11.296M | -7.453M | -65.98% |
| Q2 2024 Q2Q % growth | 6.305M 407.65% | 11.685M | -5.38M | -46.04% |
| Q1 2024 Q2Q % growth | 4.45M 579.39% | 3.2M | 1.25M | 39.06% |
| Q4 2023 Q2Q % growth | 6.215M 374.43% | 15.027M | -8.812M | -58.64% |
| Q3 2023 Q2Q % growth | 1.37M 53.93% | 3.383M | -2.013M | -59.50% |
| Q2 2023 Q2Q % growth | 1.242M 20.58% | 1.242M | 0.00% | |
| Q1 2023 Q2Q % growth | 655K -46.75% | 1.341M | -686K | -51.16% |
| Q4 2022 Q2Q % growth | 1.31M 197.73% | 975.446K | 334.554K | 34.30% |
| Q3 2022 Q2Q % growth | 890K -23.28% | 855.77K | 34.23K | 4.00% |
| Q2 2022 Q2Q % growth | 1.03M 58.46% | 731.728K | 298.272K | 40.76% |
| Q1 2022 Q2Q % growth | 1.23M 778.57% | 553.615K | 676.385K | 122.18% |
| Q4 2021 Q2Q % growth | 440K 69.23% | 402.084K | 37.916K | 9.43% |
| Q3 2021 Q2Q % growth | 1.16M 364.00% | 236.181K | 923.819K | 391.15% |
| Q2 2021 Q2Q % growth | 650K -92.50% | 195.381K | 454.619K | 232.68% |
| Q1 2021 Q2Q % growth | 140K -46.15% | 463.304K | -323.304K | -69.78% |
| Q4 2020 Q2Q % growth | 260K -38.10% | 191.944K | 68.056K | 35.46% |
| Q3 2020 Q2Q % growth | 250K -52.83% | 141.413K | 108.587K | 76.79% |
| Q2 2020 Q2Q % growth | 8.67M 1,448.21% | 426.044K | 8.244M | 1,935.00% |
| Q1 2020 Q2Q % growth | 260K -38.10% | 426.044K | -166.044K | -38.97% |
| Q4 2019 Q2Q % growth | 420K | 547.791K | -127.791K | -23.33% |
| Q3 2019 Q2Q % growth | 530K | 802.975K | -272.975K | -34.00% |
| Q2 2019 Q2Q % growth | 560K | 488.968K | 71.032K | 14.53% |
| Q1 2019 Q2Q % growth | 420K | 642.753K | -222.753K | -34.66% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.04% | -6.16% | -7.11% |
| Revenue | 0% | 0.11% | 0% | -5.03% |